Praapti Jayaswal: Unlocking the Potential of TB Healthcare with “AarogyaAI”

January 8, 2024

Each year, around 1.7 million people die from tuberculosis, and one-third of these deaths occur in India. One of the prime reasons for increasing death rates is TB isn’t diagnosed easily and takes at least four weeks to detect, making timely treatment challenging. To make this worse, sometimes specific drugs end up being ineffective in treating the individual patient. Around 29% of deaths caused by antimicrobial infections are due to drug-resistant TB. 

However, there are individuals like Praapti Jayaswal who are actively addressing this critical issue. As the founder of “AarogyaAI,” Jayaswal employs genomics and Artificial Intelligence to provide timely, cost-effective diagnoses and effective medication combating antimicrobial resistance.

The Journey Of Praapti Jayaswal: A Visionary In Healthcare Innovation

Praapti Jayaswal comes from a medical background. Her father is a spine surgeon, and her grandfather was a TB physician. Witnessing their work, she developed a strong inclination towards science and related studies.

 In 2009, Praapti completed her Bachelor of Science in Biotechnology from Mount Carmel College in Bengaluru. She continued her education at the University of Madras, earning a Master of Science (MS) in Biotechnology in 2011. In between, she also did multiple trainings at AIIMS (All India Institute of Medical Sciences, New Delhi), visited many labs and did Internships.

Later, inspired by her grandfather, she chose to do her Ph.D. in tuberculosis research at the Translational Health Science and Technology Institute in Delhi. While researching tuberculosis, she found Antimicrobial Resistance (AMR) becoming one of the most formidable health challenges. She discovered that drug resistance wasn’t just a physical problem but a mental problem, too. This realization implanted an idea to address the effective diagnosis of Drug-Resistant Tuberculosis (DR-TB).

AarogyaAI’s Inception: Innovating TB Diagnostics

While she was doing her Ph.D., she got an unexpected offer from the UK-based startup, “Entrepreneur First,” a platform encouraging individuals to build startups from scratch. She already had a plan to establish something on her own, so she joined.  

There, she met with a vibrant group of aspiring entrepreneurs, including one of her old acquaintances, Avlokita Tiwari, whom she had known since 2012. Avlokita had recently completed her MS in Bioinformatics from the University Of Turku, Finland, and was on the lookout for job prospects. 

Knowing this, Praapti approached her, proposing the idea of establishing a company together to address the impacts of drug resistance in tuberculosis that she had discovered during her research. Seeing her passion and determination, Avolikta collaborated with her. 

In 2019, they co-founded health tech startup “AarogyaAI” with the aim of combating Antimicrobial Resistance and proactively staying ahead of bugs. The Bengaluru-based company AarogyaAI functions as a Software as a Service (SaaS) platform. It has developed a quick and budget-friendly test using artificial intelligence and machine learning that rapidly identifies drug resistance in tuberculosis patients, aiding in better treatment. This test provides results within hours, avoiding trial and error.

Utilizing AWS-managed services such as Amazon Sagemaker, Amazon RDS and Elastic Load Balancing, AarogyaAI streamlines tasks that would typically require significant engineering setup and management efforts. Employing a B2B2C (business-to-business-to-consumer) model, the platform caters to diagnostic labs and hospitals as its primary customers, with plans to engage pharmaceutical companies in the future. Also, while similar tests in the market cost about 20,000, AarogyaAI’s test is priced lower, ranging from 9,000 to 12,000. 

Breakthroughs And Expansion

In January 2022, the company raised USD 700k in a seed funding round, with contributions from Info Edge, Avaana Capital, and Redstart Labs, as well as participation from existing investors Entrepreneur First and First In Ventures. The company has also secured investment from “Illumina Inc.,” the world’s largest genomics company, through the Illumina Accelerator Program based in San Francisco, USA.

“AarogyaAI” has gained multiple recognitions and awards from various entities within the Indian ecosystem, including the Minister of Health, the Government of India, Startup India, and BIRAC.

Praapti Jayaswal’s journey epitomizes a steadfast dedication to revolutionizing the medical sphere, particularly in transforming tuberculosis (TB) diagnostics and treatment through cutting-edge technology and pioneering approaches.

Also Read, Anshita's Curly Tale: Embracing Hair with “Fix My Curls”

Also Read, Empowering Sexual Wellness With “That Sassy Thing": Sachee Malhotra

Recommended Blogs

Explore inspiring stories, tips, and trends for women entrepreneurs

Blog Thumbnail
Women Listed Recommends: 10 Festive Gifting Brands Worth Discovering
A Women Listed recommendation of ten women-led festive gifting brands bringing distinct design languages to Diwali and celebration gifting—from handcrafted brass and silver-plated keepsakes to homeware, hampers and personalized gifts.
Blog Thumbnail
Selling From Home or Online? Here’s When GST Starts to Matter
GST usually becomes a real question when a small business starts selling online, across states or to larger buyers. Here is how to decide when registration is required, useful or worth reviewing.
Blog Thumbnail
Woman-Founded, Woman-Led or Women-Owned? Why the Difference Matters
Woman-founded, woman-led and women-owned are often used as if they mean the same thing. In procurement, schemes and verification, the distinction can matter.
Blog Thumbnail
Where Psychology Meets Mind Sciences: How Dr Kavita Bhargava and Neerja Handa Are Building KNeer
A mentor-student relationship evolved into a co-founder partnership. Dr Kavita Bhargava and Neerja R Handa are building KNeer as a learning platform across psychology, counselling, mind sciences and reflective practice.
Blog Thumbnail
8 Premium Mithai Brands in India for Gifting & Celebrations
A Women Listed recommendation of eight premium mithai brands bringing different approaches to Indian sweets—from traditional revival and chef-led experimentation to design-forward gifting and contemporary hampers.
Blog Thumbnail
The Next Wave of Women-Led D2C Brands Is Moving Beyond Beauty and Fashion
The next women-led consumer brands are not all entering the same crowded categories. Five emerging spaces show where sharper customer problems are creating room to grow.
Blog Thumbnail
From Snack Idea to FMCG Execution: Inside Prabhjot Kaur’s SNAAQZ Journey
Prabhjot Kaur started SNAAQZ with a product problem. Her entrepreneurial journey is now about the harder FMCG disciplines that come after launch: pricing, distribution, availability and earning the next purchase.
Blog Thumbnail
Being Online Is Not the Same as Being Findable: How to Make Your Small Business More Visible
Visibility is not the number of places your business exists. It is how easily a stranger can find, understand and trust it. Use this practical audit to identify what is missing.
Blog Thumbnail
From a Two-Person Setup to a Full-Stack Agency: Mallika Tomar's REVAMP Journey
Mallika Tomar is building REVAMP around a simple test for digital visibility: does it help the business move forward? Her founder journey spans creator insight, client trust, performance thinking and the transition from hands-on execution to team-led growth.
Blog Thumbnail
Led by Women: 15 Indian Corporate Gifting Brands for Hampers, Onboarding & Client Appreciation
A curated Women Listed guide to 15 corporate gifting brands led or co-led by women, spanning premium hampers, employee onboarding, gourmet, impact and wellness gifting.